stockrow
Friday 6 November 2026
Export RDNT’s income statement to Excel — free account
RadNet, Inc.
RDNT Healthcare Diagnostics & Research
RadNet, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.0 billion, up 11.5% from fiscal 2024.
- Revenue
- +25.0%
- EPS
- −47.4%
- Free cash flow
- −43.2%
- Total debt
- +21.2%
Quarter to June 2026, against a year earlier
78.45
1.81
−2.26%
Follow RDNT
Alert me
RadNet, Inc. (RDNT) Net income
RadNet, Inc.'s net income for fiscal 2025 was $17.0M, down 56.1% from $38.8M in fiscal 2024. Over the twelve months to 30 June 2026 it was $19.3M. Over the past ten years it has ranged from −$1.7M (fiscal 2020) to $44.3M (fiscal 2021); the current reading is higher than 45% of that period. RadNet, Inc. ranks 20th of 49 Diagnostics & Research companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2025 | $17.0M | (56.11%) |
| FY2024 | $38.8M | 28.02% |
| FY2023 | $30.3M | (9.73%) |
| FY2022 | $33.6M | (24.17%) |
| FY2021 | $44.3M | — |
| FY2020 | −$1.7M | — |
| FY2019 | $23.4M | (38.53%) |
| FY2018 | $38.1M | 1,737.73% |
| FY2017 | $2.1M | (74.08%) |
| FY2016 | $8.0M | (7.34%) |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Jun 2026 | $20.3M | — |
| Mar 2026 | −$24.7M | — |
| Dec 2025 | $9.9M | (29.00%) |
| Sep 2025 | $13.9M | (39.70%) |
| 42 more quarters | Free account |
Against its own ten years
Low −$1.7M
High $44.3M
Ten-year median
$23.4M
Current reading's percentile
45
Net income against peers
| Company | Net income |
|---|---|
| ICLR ICON PLC compare | $448.7M |
| QGEN QIAGEN N.V. compare | $409.3M |
| SHC Sotera Health Company compare | $173.5M |
| CDNA CareDx, Inc. compare | $128.6M |
| VCYT Veracyte, Inc. compare | $126.8M |
| BLLN BillionToOne, Inc. compare | $49.4M |
| RDNT RadNet, Inc. | $19.3M |
| ADPT Adaptive Biotechnologies Corporation compare | −$70.7M |
| GRAL GRAIL, Inc. compare | −$406.2M |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on RDNT
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement